All stocks Β· UNJHAFOR
UF

Unjha Formulations Ltd.

UNJHAFOR BSE Drug Manufacturers - Specialty & Generic Healthcare

Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor unde…

ISIN INE576D01015
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron, Fibron SF and Fibron SF (Sugar Free) names. It also exports its products. Unjha Formulations Limited was incorporated in 1994 and is based in Sidhpur, India.

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 3.31 3.33 4.44 4.29 3.63 2.44 3.76 3.78 3.95 4.43 5.55 4.76 3.76
Expenses 3.12 3.78 4.16 3.50 3.21 2.70 3.52 3.89 3.23 4.37 5.14 4.87 3.54
Operating Profit 0.19 -0.45 0.28 0.79 0.42 -0.26 0.24 -0.11 0.72 0.06 0.41 -0.11 0.22
OPM % 5.74 -13.51 6.31 18.41 11.57 -10.66 6.38 -2.91 18.23 1.35 7.39 -2.31 5.85
Other Income 0.00 0.00 0.00 0.06 0.00 0.00 0.01 0.02 0.00 0.01 0.00 0.01 -0.01
Depreciation 0.04 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.02
Profit before tax 0.15 -0.49 0.24 0.82 0.39 -0.29 0.23 -0.11 0.70 0.00 0.39 -0.12 0.19
Tax % 0.00 51.02 0.00 0.00 0.00 41.38 0.00 0.00 0.00 β€” 0.00 0.00 0.00
Net Profit 0.16 -0.74 0.24 0.82 0.39 -0.41 0.22 -0.11 0.70 -0.18 0.39 -0.12 0.18
EPS in Rs 0.36 -1.65 0.54 1.83 0.87 -0.92 0.49 -0.25 1.56 -0.40 0.87 -0.27 0.40

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 15.5913.8618.5013.1514.169.9610.5911.2811.3012.2310.368.84
Expenses 14.6413.3417.9312.7113.849.8310.3410.9810.9611.8610.008.65
Operating Profit 0.950.520.570.440.320.130.250.300.340.370.360.19
OPM % 6.093.753.083.352.261.312.362.663.013.033.472.15
Other Income 0.160.110.010.030.190.220.260.100.040.110.080.09
Interest 0.010.010.050.060.130.170.120.010.020.100.100.01
Depreciation 0.140.100.080.080.080.080.080.090.100.090.080.09
Profit before tax 0.960.520.450.330.300.100.310.300.260.290.260.18
Tax % 26.0423.0840.0015.1516.670.000.000.000.000.000.000.00
Net Profit 0.700.410.280.280.250.100.310.300.260.300.260.17
EPS in Rs 1.560.920.620.620.560.220.690.670.580.670.580.38
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 4.484.484.484.484.484.484.484.484.484.484.484.48
Reserves -0.64-1.34-1.75-2.03-2.31-2.56-2.67-2.97-3.27-3.54-3.83-4.09
Borrowings 0.000.000.000.000.000.000.000.000.000.050.000.40
Other Liabilities 1.671.422.200.961.281.611.902.152.752.792.282.51
Total Liabilities 5.514.564.933.413.453.533.713.663.963.782.933.30
Fixed Assets 1.301.201.121.101.071.121.141.121.161.221.031.09
CWIP 0.000.000.000.000.000.000.000.000.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 4.213.363.812.312.382.412.572.542.802.561.902.21
Total Assets 5.514.564.933.413.453.533.713.663.963.782.933.30

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 1.24-0.041.03-0.260.28-0.700.39-0.120.140.390.41-0.70
Cash from Investing Activity -0.23-0.18-0.11-0.10-0.02-0.06-0.100.040.06-0.28-0.02-0.09
Cash from Financing Activity -0.01-0.01-0.05-0.060.000.000.000.23-0.050.05-0.400.40
Net Cash Flow 1.00-0.230.86-0.420.25-0.770.290.160.150.15-0.01-0.38
Free Cash Flow 1.01-0.220.92-0.360.26-0.760.29-0.080.200.110.39-0.78
CFO/OP % 156.0019.00189.00-48.0088.00-408.00204.00-37.0041.00105.00114.00-368.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 31.6139.7731.7629.1418.0435.9139.6443.3625.1919.4028.5428.08
Inventory Days 19.1032.9229.5638.9234.0855.6021.3722.9239.4040.8322.7635.62
Days Payable 39.7137.3947.8532.1039.8177.3582.7987.50106.2298.2094.35122.48
Cash Conversion Cycle 10.9935.2913.4735.9712.3114.16-21.79-21.22-41.63-37.97-43.06-58.78
Working Capital Days 21.3134.2414.6037.1917.2722.72-9.31-8.41-21.96-24.17-28.19-46.66
ROCE % 27.7918.0619.3116.8821.0314.4825.9022.7925.4547.5650.0037.62

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92
Public 63.07 63.08 63.08 63.08 63.08 63.07 63.07 63.07 63.08 63.08 63.08 63.08
No. of Shareholders 4,223 4,235 4,251 4,284 4,213 4,273 4,208 3,969 3,985 3,933 4,012 3,993

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 30 Oct 2023 β€” β€” β€” E.G.M.

Announcements

5 filings